Malaria Treatment Market Anticipated to Grow at 6% CAGR Through 2029: Industry Report

 Developed by experienced analysts, this report offers in-depth insights for understanding competition and customer behavior in the malaria treatment industry.

What Is The Projected Market Size & Growth Rate Of The Malaria Treatment Market?
The malaria treatment market size has grown steadily in recent years. It will grow from $1.55 billion in 2024 to $1.61 billion in 2025 at a compound annual growth rate (CAGR) of 3.9%. The growth in the historic period can be attributed to the discovery of effective drugs, vector control efforts, global health initiatives, scientific research, and health infrastructure development

The malaria treatment market size is expected to see strong growth in the next few years. It will grow to $2.03 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to drug resistance monitoring, climate change impact, precision medicine and genomic approaches, healthcare financing reforms, and integration of digital health solutions. Major trends in the forecast period include epidemiological surveillance enhancement, alternative medicine integration, malaria vaccine development, data-driven treatment programs, and education and training programs.

Get your free sample today:
Malaria Treatment Market Report 2025, Size and Analysis By 2034 Sample

What Is The Crucial Factor Driving The Global Malaria Treatment Market?
The high incidence of malaria is expected to propel the growth of the malaria treatment market going forward. Malaria refers to a potentially life-threatening mosquito-borne disease caused by the Plasmodium parasite, characterized by recurring fever and other flu-like symptoms. This shift has resulted from poverty, limited access to healthcare services, climate change, lack of malaria control measures, and drug resistance. Malaria treatment helps to effectively manage and cure the infection caused by the Plasmodium parasite. For instance, according to the World malaria report 2023 by World Health Organization, a Switzerland-based intergovernmental organization, global malaria cases reached 249 million in 2022, an increase of five million compared to 2021. Therefore, the high incidence of malaria is driving the growth of the malaria treatment market.

Segment Covered In The Malaria Treatment Market Report
The malaria treatment market covered in this report is segmented –

1) By Treatment: Prescription Medications, Vaccines, Diagnostic Tests, Other Treatments
2) By Route Of Administration: Oral, Parenteral, Intravenous
3) By Distribution Channel: Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
4) By End User: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:
1) By Prescription Medications: Antimalarial Drugs, Prophylactic Medications
2) By Vaccines: RTS,S Or AS01, Other Experimental Vaccines
3) By Diagnostic Tests: Rapid Diagnostic Tests, Microscopy-Based Tests, Polymerase Chain Reaction (PCR) Tests
4) By Other Treatments: Supportive Care, Herbal Remedies, Vector Control Measures

What Are The Prominent Trends In The Malaria Treatment Market?
Major companies operating in the malaria treatment market are developing technologies such as the VERV Program to enhance the efficiency and effectiveness of malaria diagnostics and treatments, ultimately aiming to reduce the burden of the disease in endemic regions. The VERV Program is an EPA initiative that encourages the development of new mosquito control products to fight diseases like malaria by offering expedited review vouchers for registration. For instance, in December 2023, the Environmental Protection Agency (EPA), a US-based government agency, launched the Vector Expedited Review Voucher (VERV) Program. The VERV Program will provide financial incentives to companies that develop new pesticides specifically targeting mosquito populations resistant to traditional insecticides. The program will facilitate faster registration processes for qualifying products, thereby expediting their availability in the market.

Key Player In The Malaria Treatment Market
Major companies operating in the malaria treatment market include Pfizer Inc., Merck & Co., Johnson & Johnson, Roche Holding AG, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca Plc, GlaxoSmithKline PLC., Takeda Pharmaceutical Company Limited, Sumitomo Chemical Co. Ltd., Viatris Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Serum Institute of India, Cipla Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., Zydus Lifesciences Limited, Ipca Laboratories Ltd., Chongqing Holley Pharmaceutical Co. Ltd., Zydus Lifesciences Ltd., Medicines Sans Frontières, Strides Pharma Science Limited, Swiss Tropical and Public Health Institute (Swiss TPH), AdvaCare Pharma USA LLC, Medicines for Malaria Venture (MMV), VLP Therapeutics LLC, Actiza Pharmaceutical Private Limited

View the full malaria treatment market report here:
Malaria Treatment Market Report 2025, Size and Analysis By 2034

Global Malaria Treatment Market - Regional Insights:
Middle East and Africa was the largest region in the malaria treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malaria treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

Market Research Reports

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: The Business Research Company | LinkedIn